GTHX Annual CFI
$2.81 M
+$53.34 M+105.56%
31 December 2023
Summary:
As of January 26, 2025, GTHX annual cash flow from investing activities is $2.81 million, with the most recent change of +$53.34 million (+105.56%) on December 31, 2023. During the last 3 years, it has risen by +$2.66 million (+1748.68%).GTHX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Quarterly CFI
$229.00 K
-$5.06 M-95.67%
30 June 2024
Summary:
As of January 26, 2025, GTHX quarterly cash flow from investing activities is $229.00 thousand, with the most recent change of -$5.06 million (-95.67%) on June 30, 2024. Over the past year, it has dropped by -$117.00 thousand (-33.82%).GTHX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX TTM CFI
$5.07 M
-$117.00 K-2.25%
30 June 2024
Summary:
As of January 26, 2025, GTHX TTM cash flow from investing activities is $5.07 million, with the most recent change of -$117.00 thousand (-2.25%) on June 30, 2024. Over the past year, it has increased by +$51.84 million (+110.85%).GTHX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +105.6% | -33.8% | +110.8% |
| 3 y3 years | +1748.7% | -33.8% | +110.8% |
| 5 y5 years | +496.3% | +230.1% | +318.2% |
GTHX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -96.8% | -2.3% |
G1 Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $229.00 K(-95.7%) | $5.07 M(-2.3%) |
| Mar 2024 | - | $5.29 M(-169.2%) | $5.19 M(+84.7%) |
| Dec 2023 | $2.81 M(-105.6%) | -$7.65 M(-206.2%) | $2.81 M(-128.4%) |
| Sept 2023 | - | $7.20 M(+1981.2%) | -$9.90 M(-78.8%) |
| June 2023 | - | $346.00 K(-88.1%) | -$46.77 M(-1.8%) |
| Mar 2023 | - | $2.91 M(-114.3%) | -$47.62 M(-5.8%) |
| Dec 2022 | -$50.53 M(<-9900.0%) | -$20.36 M(-31.4%) | -$50.53 M(+67.5%) |
| Sept 2022 | - | -$29.66 M(+5761.9%) | -$30.17 M(+5861.9%) |
| June 2022 | - | -$506.00 K(<-9900.0%) | -$506.00 K(<-9900.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2021 | - | $0.00(0.0%) | $152.00 K(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $152.00 K(0.0%) |
| Dec 2020 | $152.00 K | $0.00(-100.0%) | $152.00 K(-116.0%) |
| Sept 2020 | - | $152.00 K(>+9900.0%) | -$948.00 K(-59.2%) |
| June 2020 | - | $0.00(0.0%) | -$2.32 M(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $0.00(-100.0%) | -$2.50 M(-8.0%) |
| Dec 2019 | -$2.72 M(+283.1%) | -$1.10 M(-10.1%) | -$2.72 M(+57.3%) |
| Sept 2019 | - | -$1.22 M(+595.5%) | -$1.73 M(+88.3%) |
| June 2019 | - | -$176.00 K(-18.5%) | -$917.00 K(+7.4%) |
| Mar 2019 | - | -$216.00 K(+94.6%) | -$854.00 K(+20.5%) |
| Dec 2018 | -$709.00 K(+141.2%) | -$111.00 K(-73.2%) | -$709.00 K(+14.0%) |
| Sept 2018 | - | -$414.00 K(+266.4%) | -$622.00 K(+40.1%) |
| June 2018 | - | -$113.00 K(+59.2%) | -$444.00 K(+26.1%) |
| Mar 2018 | - | -$71.00 K(+195.8%) | -$352.00 K(+19.7%) |
| Dec 2017 | -$294.00 K(+17.6%) | -$24.00 K(-89.8%) | -$294.00 K(-5.5%) |
| Sept 2017 | - | -$236.00 K(+1023.8%) | -$311.00 K(+56.3%) |
| June 2017 | - | -$21.00 K(+61.5%) | -$199.00 K(-3.7%) |
| Mar 2017 | - | -$13.00 K(-68.3%) | -$206.70 K(-17.3%) |
| Dec 2016 | -$250.00 K(+187.4%) | -$41.00 K(-66.9%) | -$250.00 K(+19.6%) |
| Sept 2016 | - | -$124.00 K(+332.1%) | -$209.00 K(+145.9%) |
| June 2016 | - | -$28.70 K(-49.0%) | -$85.00 K(+51.0%) |
| Mar 2016 | - | -$56.30 K | -$56.30 K |
| Dec 2015 | -$87.00 K | - | - |
FAQ
- What is G1 Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for G1 Therapeutics?
- What is G1 Therapeutics annual CFI year-on-year change?
- What is G1 Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for G1 Therapeutics?
- What is G1 Therapeutics quarterly CFI year-on-year change?
- What is G1 Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for G1 Therapeutics?
- What is G1 Therapeutics TTM CFI year-on-year change?
What is G1 Therapeutics annual cash flow from investing activities?
The current annual CFI of GTHX is $2.81 M
What is the all time high annual CFI for G1 Therapeutics?
G1 Therapeutics all-time high annual cash flow from investing activities is $2.81 M
What is G1 Therapeutics annual CFI year-on-year change?
Over the past year, GTHX annual cash flow from investing activities has changed by +$53.34 M (+105.56%)
What is G1 Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of GTHX is $229.00 K
What is the all time high quarterly CFI for G1 Therapeutics?
G1 Therapeutics all-time high quarterly cash flow from investing activities is $7.20 M
What is G1 Therapeutics quarterly CFI year-on-year change?
Over the past year, GTHX quarterly cash flow from investing activities has changed by -$117.00 K (-33.82%)
What is G1 Therapeutics TTM cash flow from investing activities?
The current TTM CFI of GTHX is $5.07 M
What is the all time high TTM CFI for G1 Therapeutics?
G1 Therapeutics all-time high TTM cash flow from investing activities is $5.19 M
What is G1 Therapeutics TTM CFI year-on-year change?
Over the past year, GTHX TTM cash flow from investing activities has changed by +$51.84 M (+110.85%)